Almac Discovery
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase I Dose-escalation Study of Subcutaneous ALM201 in Patients With Advanced Ovarian Cancer and Other Solid Tumours (NCT03427073) | Almac Discovery | 2015-04-27 |
Track Almac Discovery automatically
Every clearance here is in the API, with alerts when new ones post.